Danaher Corporation $DHR Stock Holdings Lifted by Defender Capital LLC.

Defender Capital LLC. raised its position in Danaher Corporation (NYSE:DHR) by 0.3% during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 157,041 shares of the conglomerate’s stock after purchasing an additional 498 shares during the quarter. Danaher makes up approximately 10.5% of Defender Capital LLC.’s holdings, making the stock its 4th biggest position. Defender Capital LLC.’s holdings in Danaher were worth $31,022,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds also recently made changes to their positions in the stock. NorthRock Partners LLC lifted its position in shares of Danaher by 74.7% in the second quarter. NorthRock Partners LLC now owns 12,248 shares of the conglomerate’s stock worth $2,420,000 after buying an additional 5,236 shares during the last quarter. Envestnet Portfolio Solutions Inc. lifted its position in shares of Danaher by 4.6% in the second quarter. Envestnet Portfolio Solutions Inc. now owns 78,933 shares of the conglomerate’s stock worth $15,592,000 after buying an additional 3,436 shares during the last quarter. Delaney Dennis R lifted its position in shares of Danaher by 2.3% in the second quarter. Delaney Dennis R now owns 25,407 shares of the conglomerate’s stock worth $5,019,000 after buying an additional 579 shares during the last quarter. Sequoia Financial Advisors LLC lifted its position in shares of Danaher by 9.7% in the second quarter. Sequoia Financial Advisors LLC now owns 21,644 shares of the conglomerate’s stock worth $4,276,000 after buying an additional 1,909 shares during the last quarter. Finally, Vest Financial LLC lifted its position in shares of Danaher by 39.2% in the second quarter. Vest Financial LLC now owns 7,465 shares of the conglomerate’s stock worth $1,475,000 after buying an additional 2,104 shares during the last quarter. Institutional investors and hedge funds own 79.05% of the company’s stock.

Insider Buying and Selling at Danaher

In other news, Director Teri List sold 2,778 shares of the company’s stock in a transaction that occurred on Friday, August 22nd. The stock was sold at an average price of $211.06, for a total value of $586,324.68. Following the sale, the director directly owned 20,751 shares in the company, valued at approximately $4,379,706.06. This represents a 11.81% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this link. Corporate insiders own 11.20% of the company’s stock.

Analyst Ratings Changes

A number of analysts have weighed in on the company. UBS Group reduced their price target on Danaher from $240.00 to $225.00 and set a “buy” rating for the company in a research report on Wednesday, July 23rd. Evercore ISI boosted their price objective on Danaher from $226.00 to $245.00 and gave the stock an “outperform” rating in a research report on Tuesday, October 7th. Robert W. Baird boosted their price objective on Danaher from $225.00 to $226.00 and gave the stock an “outperform” rating in a research report on Friday, July 18th. Rothschild Redb cut Danaher from a “strong-buy” rating to a “hold” rating in a research report on Wednesday, October 8th. Finally, Bank of America cut their price objective on Danaher from $230.00 to $220.00 and set a “buy” rating for the company in a research report on Monday, September 22nd. Seventeen investment analysts have rated the stock with a Buy rating and six have given a Hold rating to the company. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $244.60.

Danaher Trading Up 1.4%

Danaher stock opened at $205.36 on Tuesday. The business has a 50 day moving average price of $200.82 and a two-hundred day moving average price of $197.06. The company has a quick ratio of 1.22, a current ratio of 1.62 and a debt-to-equity ratio of 0.32. The stock has a market cap of $147.05 billion, a price-to-earnings ratio of 43.69, a price-to-earnings-growth ratio of 2.88 and a beta of 0.77. Danaher Corporation has a 12 month low of $171.00 and a 12 month high of $279.41.

Danaher (NYSE:DHR) last posted its quarterly earnings results on Tuesday, July 22nd. The conglomerate reported $1.80 EPS for the quarter, beating the consensus estimate of $1.64 by $0.16. The firm had revenue of $5.94 billion during the quarter, compared to analysts’ expectations of $5.83 billion. Danaher had a return on equity of 10.70% and a net margin of 14.21%.The company’s revenue for the quarter was up 3.4% on a year-over-year basis. During the same quarter in the prior year, the firm posted $1.72 EPS. Danaher has set its FY 2025 guidance at 7.700-7.800 EPS. As a group, equities analysts forecast that Danaher Corporation will post 7.63 EPS for the current year.

Danaher Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, October 31st. Stockholders of record on Friday, September 26th will be paid a $0.32 dividend. This represents a $1.28 annualized dividend and a dividend yield of 0.6%. The ex-dividend date is Friday, September 26th. Danaher’s dividend payout ratio is currently 27.23%.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.